Trial Profile
A Phase 2, Single-center, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group Study of a Single Dose of IW-6118, in Patients Undergoing Third Molar Extraction
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Mar 2019
Price :
$35
*
At a glance
- Drugs IW 6118 (Primary) ; Naproxen sodium
- Indications Dental pain; Postoperative pain
- Focus Adverse reactions
- Sponsors Ironwood Pharmaceuticals
- 23 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jun 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 27 Apr 2010 New trial record